These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6979593)

  • 1. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
    Gootz TD; Sanders CC; Goering RV
    J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of resistance determinants to cefamandole and cefoxitin in Enterobacter cloacae strains.
    Vuye A
    Microbios; 1983; 38(153-154):159-69. PubMed ID: 6606106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.
    Ott JL; Turner JR; Mahoney DF
    Antimicrob Agents Chemother; 1979 Jan; 15(1):14-9. PubMed ID: 311615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.
    Cullmann W; Dick W
    Eur J Clin Microbiol; 1985 Feb; 4(1):34-40. PubMed ID: 3872794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.
    Beckwith DG; Jahre JA
    J Clin Microbiol; 1980 Oct; 12(4):517-20. PubMed ID: 6968320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactamase activity and cross-resistance to different cephalosporins of in vitro selected cefamandole-resistant variants of Enterobacter cloacae.
    Vuye A
    J Pharm Belg; 1982; 37(4):267-72. PubMed ID: 6982969
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL; Freundlich LF; Quraishi MA
    Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp.
    Lindh E; Dornbusch K; Jalakas K; Forsgren A
    APMIS; 1990 May; 98(5):462-70. PubMed ID: 2162681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to cefamandole: a collaborative study of emerging clinical problems.
    Sanders CC; Moellering RC; Martin RR; Perkins RL; Strike DG; Gootz TD; Sanders WE
    J Infect Dis; 1982 Jan; 145(1):118-25. PubMed ID: 6274965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of glycine enhancement with cefoxitin induction of class 1 beta-lactamase production in Enterobacter cloacae ATCC 13047.
    Gatus BJ; Bell SM; Jimenez AS
    J Antimicrob Chemother; 1988 Feb; 21(2):163-70. PubMed ID: 3258859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of resistance to cephalosporins in clinical strains of Citrobacter spp.
    Gootz TD; Jackson DB; Sherris JC
    Antimicrob Agents Chemother; 1984 May; 25(5):591-5. PubMed ID: 6610388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae.
    Peter K; Korfmann G; Wiedemann B
    Rev Infect Dis; 1988; 10(4):800-5. PubMed ID: 3263688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamases.
    Ashby J; Kirkpatrick B; Piddock LJ; Wise R
    J Antimicrob Chemother; 1987 Jul; 20(1):15-22. PubMed ID: 3497914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.
    Papanicolaou GA; Medeiros AA
    Diagn Microbiol Infect Dis; 1991; 14(1):85-7. PubMed ID: 2013214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.
    Olson B; Weinstein RA; Nathan C; Kabins SA
    J Antimicrob Chemother; 1983 Apr; 11(4):299-310. PubMed ID: 6602122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.
    Seeberg AH; Tolxdorff-Neutzling RM; Wiedemann B
    Antimicrob Agents Chemother; 1983 Jun; 23(6):918-25. PubMed ID: 6351733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of disk approximation and agar dilution induction tests for demonstration of in vitro antagonism of cefotaxime by cefoxitin in Enterobacter species.
    Chandler SW; Nolte FS
    Eur J Clin Microbiol; 1987 Aug; 6(4):476-8. PubMed ID: 3499317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.